AnalysisBusiness · Clinics & Practices

Neko brings clinician-led body scans to New York for $499

A 60-minute visit, same-visit results and a clinician in the room. Why the model could work for healthspan where Forward's pods did not.

Oct 5, 2026By longevitydocs™ editors
A Neko Health results screen showing a 3D body model, heart age and a health timeline
Image: Neko Health

Neko Health opened its first US clinic on September 24 at 300 Lafayette Street in SoHo. For $499, HSA and FSA eligible, a member gets a 60-minute, radiation-free body scan, a blood draw with results in the same visit, and a consultation with a clinician before leaving.

The company, co-founded by Spotify's Daniel Ek and CEO Hjalmar Nilsonne, opened its first clinic in Stockholm in 2023 and now runs eight in Sweden and the UK. It says it has delivered more than 100,000 scans, has more than 25,000 people on its New York waitlist and 350,000 worldwide, and plans clinics in Miami, Washington and San Francisco. In July it raised $700 million at a valuation of nearly $7 billion.

What you get

The visit is organized into five modules. Everything except the blood draw is non-invasive, and nothing uses radiation.

1. Skin and body imaging

  • A full-body scan in a booth fitted with about 70 sensors, including volumetric cameras, that captures around 50 million data points in seconds.
  • Every visible mole and skin marking is photographed, indexed and mapped, so changes can be compared visit to visit. A dermatologist reviews flagged lesions, and the clinician can examine any spot with a dermatoscope.
  • Body composition, including body fat and visceral fat, plus height and weight.

2. Heart and circulation

  • A resting ECG with chest electrodes to assess the heart's electrical activity.
  • Blood pressure and pulse measurements at several points on the body to assess arterial health.
  • A laser-based microcirculation check of the smallest vessels, an early marker of vascular dysfunction.

3. Blood

  • A blood draw processed on site, with results in the same visit. Neko says the US panel covers more than 50 biomarkers across nine areas, including heart health, metabolism, immunity and inflammation.
  • Reviewers describe cholesterol (LDL and HDL) and other lipids, blood sugar markers, inflammation markers, and liver and kidney function.

4. Functional checks

  • Grip strength with a handheld dynamometer, one of the simplest and best-validated predictors of mortality and frailty.
  • Eye pressure with an air-puff tonometer, a screen for glaucoma risk.
  • Vital signs, including resting heart rate.

5. Clinician consultation

  • A clinician walks through every result before you leave and agrees next steps. Neko's in-house cardiologists and dermatologists handle follow-up reviews and referrals at no extra cost.
  • In Europe, the results also feed a model that projects health trajectories at ages 60, 70 and 80, and members track changes across visits in the Neko app.

What it leaves out

This is not an imaging exam. There is no MRI, CT or ultrasound, so it does not look at organs, coronary calcium or the brain. Reviewers note that it does not include extensive hormone panels, genetic testing or a deep vitamin and mineral workup, and it does not replace age-based cancer screening such as colonoscopy, mammography or cervical screening.

Why it matters for healthspan

Most of what shortens healthspan is silent for years: rising blood pressure, insulin resistance, atherogenic lipids, visceral fat, a changing mole. A single visit that measures all of it, at a price closer to a specialist co-pay than a concierge membership, lowers the barrier to finding risk early.

The bigger value is repetition. A baseline becomes useful when it turns into a trajectory. Neko says 75% of members rebook after their first visit, and that returning members improve five of seven key biomarkers between visits. Those are the company's own figures, not peer-reviewed outcomes. The evidence that broad screening of healthy adults improves hard outcomes is still limited, and every scan creates incidental findings that someone has to own.

Experience is not enough

Experience matters in healthcare. It is not enough. Forward raised $657 million, reached a $1 billion valuation, and built sleek primary care clinics and self-serve AI CarePods in malls and offices. It shut down abruptly in November 2024, leaving patients scrambling for their records. Observers pointed to operational complexity, expensive real estate and a product that put technology ahead of clinical care.

Neko's bet is different in one important way: the clinician is in the room. The hardware gathers the data, but a clinician delivers the results the same day, and specialists own the follow-up. That is what turns a scan into care.

Retail healthcare is coming

Demand for prevention is outrunning the system that is supposed to deliver it. Patients want answers now, not a six-week wait for an annual physical. Expect more retail health concepts in high-traffic neighborhoods, from scan clinics to longevity studios. The ones that last will pair a great experience with real clinical ownership and a clear path back to the patient's own physician.

What it means for physicians

  • Patients will arrive with scan reports. Ask for the raw results and the clinician's notes, not just the summary.
  • Treat a first scan as a baseline. The trend over repeat visits is where the clinical signal is.
  • Agree on who owns incidental findings before they happen, especially skin lesions and borderline cardiac results.
  • Retail clinics are a referral source. Physicians who make it easy to receive those patients will gain them.
By
longevitydocs™ editors
Published
Oct 5, 2026
Sources
Primary source
Neko Health, New York opening press release, August 18, 2026
Fitt Insider, Neko Health Series C, July 15, 2026
Neko Health, Health Scan page (US)
Get The Gloss, PureWow and TechCrunch first-hand reviews of the Neko scan
Fierce Healthcare, Forward shutdown, November 2024

Share this article

WRITTEN BYlongevitydocs™ editorsCurated by the longevitydocs™ editorial team from The Sunday Newsletter

Read more

All stories
FROM THE NETWORK

The Buzz in the Chat

What physicians are discussing across the longevitydocs™ network.

Explore the discussion →